Paper: Real-World Outcomes with Fedratinib Therapy in Patients Who Discontinued Ruxolitinib for Primary Myelofibrosis
Real-world Outcomes of Fedratinib in Patients with Myelofibrosis who Discontinued Ruxolitinib
Real-world Outcomes of Fedratinib in Patients with Myelofibrosis who Discontinued Ruxolitinib
Discover how Hiscox utilized UiPath communications mining to identify customer needs, address business challenges, and automate some of their most common service processes.
The CardioNerds case report series continues with a discussion about a case featuring pericarditis with Beth Israel Deaconess Medical Center
Abstract. Introduction: Twelve modifiable risk factors (RFs) account for 40% of dementia cases worldwide. However, limited data exist on such factors in middle- and low-income…
Tips on how to read the medical literature
Upregulation of a cluster of primate-specific KRAB zinc finger proteins in cancer cells prevents replicative stress and inflammation by regulating heterochromatin maintenance, which could facilitate…
Developed by doctors, MedShr is the easiest & safest way for medical professionals to discover, discuss and share clinical cases and medical images. Join our…
Journal of the American Geriatrics Society (JAGS) is the go-to geriatrics journal for clinical aging research including education, clinical practice and public policy.
Abstract. Activation of effector T cells leads to upregulation of PD-1, which can inhibit T-cell activity following engagement with its ligand PD-L1. Post-translational modifications (PTM),…
Undersea cable companies that extend internet services to West and Central Africa estimate that it could take five weeks to repair.
New Blackwell GPU, NVLink and Resilience Technologies Enable Trillion-Parameter-Scale AI Models New Tensor Cores and TensorRT- LLM Compiler Reduce LLM Inference Operating Cost and Energy…